Skip to content
10-K

Annual Report

Senti Biosciences Holdings, Inc. SNTI

0001628280-26-021580

← back to feed
Filed
Mar 27, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 19, 2026 31.14M sh
Shares Diluted FY 2025 · Dec 31, 2025 22.48M sh
Shares Diluted FY 2025 · Dec 31, 2024 4.6M sh
Capex FY 2025 · Dec 31, 2025 $196K
Capex FY 2025 · Dec 31, 2024 $26K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$43.44M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$41.4M
Cash And Equivalents FY 2025 · Dec 31, 2025 $16.42M
Cash And Equivalents FY 2025 · Dec 31, 2024 $48.28M
Stockholders Equity FY 2025 · Dec 31, 2025 $5.59M
Stockholders Equity FY 2025 · Dec 31, 2024 $25.65M
Stockholders Equity FY 2025 · Dec 31, 2023 $66.91M
Current Liabilities FY 2025 · Dec 31, 2025 $13.97M
Current Liabilities FY 2025 · Dec 31, 2024 $13.15M
Total Liabilities FY 2025 · Dec 31, 2025 $45.63M
Total Liabilities FY 2025 · Dec 31, 2024 $47.09M
Current Assets FY 2025 · Dec 31, 2025 $23.27M
Current Assets FY 2025 · Dec 31, 2024 $58.96M
Total Assets FY 2025 · Dec 31, 2025 $51.22M
Total Assets FY 2025 · Dec 31, 2024 $97.84M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.73
Eps Diluted FY 2025 · Dec 31, 2024 −$12.03
Eps Basic FY 2025 · Dec 31, 2025 −$2.73
Eps Basic FY 2025 · Dec 31, 2024 −$12.03
Sga Expense FY 2025 · Dec 31, 2025 $26.16M
Sga Expense FY 2025 · Dec 31, 2024 $26.37M
Rd Expense FY 2025 · Dec 31, 2025 $37.59M
Rd Expense FY 2025 · Dec 31, 2024 $34.36M
Net Income FY 2025 · Dec 31, 2025 −$61.44M
Net Income FY 2025 · Dec 31, 2024 −$52.79M
Operating Income FY 2025 · Dec 31, 2025 −$68.78M
Operating Income FY 2025 · Dec 31, 2024 −$61.04M
Revenue FY 2025 · Dec 31, 2025 $22K
Revenue FY 2025 · Dec 31, 2024 $0